Orthobiologics

Active Implants enrolled the 100th patient in clinical trials evaluating the NUsurface® Meniscus Implant to treat persistent knee pain from damaged...

Studies indicate that Anika Therapeutics’ HYALOFAST® scaffold + autologous adult MSCs present a viable option to treat knee cartilage lesions, regardless of...

MiMedx filed to initiate an Investigational New Drug Phase III clinical study comparing AmnioFix® Injectable to saline placebo in the treatment of Achilles Tendonitis....

MiMedx commenced a Phase III study to evaluate AmnioFix Injectable allograft vs. placebo in the treatment of Plantar Fasciitis. ...

AlloSource launched AlloFuse® Select CM cellular allograft for use in spinal, orthopaedic and neurologic procedures. ...

Anika Therapeutics received regulatory approval in India for MONOVISC® viscosupplement to treat OA pain in all synovial joints....

A 6-year, randomized clinical trial is underway to evaluate use of a patient’s own stem cells to regenerate knee cartilage....

Histogenics completes enrollment of 245 patients in its NeoCart Phase III clinical trial....

ChoiceSpine launched a biologics portfolio, adding allograft, synthetic bone graft and amnion offerings to complement its spinal hardware portfolio....

Bone Therapeutics received notice that the European Patent Office will grant the company a patent covering its allogeneic cell therapy...